Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.44 -0.11%   SPY: 132.20 +0.17%
Quote Spy GALT NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Galectin Therapeutics (GALT)

@ 3:59 PM
Click the portfolio to add GALT:
Close [X]
+ Add GALT to Portfolio
  
  Last Trade: $2.08 +0.12 (6.12%)
  Volume: 175,501 403% of avg daily volume
       
  Avg Volume: 43,553
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 1.97 - 2.13
  Open: 2.00
  Previous Close: 1.96
  52-wk Range: 1.96 - 8.28
  Market Cap: 30.5M
  P/E: -2.0
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy GALT

? Pro holders
? Member holders
? Items submitted
Additional GALT resources



Customize Links
To see which Pros and tickerspy members own GALT Sign up now
Latest GALT Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Catastrophic Success
BTX  GALT  
Linked by The Big Picture - December 20, 10:00PM from (www.ritholtz.com)
Catastrophic Success John Mauldin December 20, 2011 ~~~ New readers to my musings often find it interesting, when they meet  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tough Choices, Big Opportunities
GALT  
Linked by The Big Picture - October 02, 06:16AM from (www.ritholtz.com)
Tough Choices, Big Opportunities By John Mauldin September 30, 2011 ~~~ Tough Choices, Big Opportunities Ireland, Geneva,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Accredited Members Fall 2010 Small/Micro Cap Investment Conference Features Exciting List of Participating Companies
AMS  MZEI  ZYXI  BNET  GDTK  ECTE  CUI  VCTZF  GALT  BWMS  ZORM  NGHI  AHRO  ACCM  BEYS  RVUE  
Linked by GlobeNewswire - September 16, 08:00PM from (www.globenewswire.com)
COLORADO SPRINGS, Colo., Sept. 16, 2010 (GLOBE NEWSWIRE) -- Attendees of the Accredited Members (OTCBB:ACCM) Fall Small/Micro  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BUYINS.NET Issues Pro-Pharmaceuticals SqueezeTrigger Report
GALT  
Linked by GlobeNewswire - September 01, 08:30AM from (www.globenewswire.com)

NEWPORT BEACH, Calif., Sept. 1, 2010 (GLOBE NEWSWIRE) -- BUYINS.NET, http://www.buyins.net, a leading provider of  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pro-Pharmaceuticals Receives First Commercial Order for DAVANAT®
GALT  
Linked by BusinessWire - June 22, 07:43AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), the leading developer of therapeutics that target Galectin receptors to treat cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Former Glaxo Smith Kline Chief Medical Officer Peter G. Traber, M.D., Named Chief Medical Officer of Pro-Pharmaceuticals
GALT  
Linked by BusinessWire - June 15, 07:00AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), the leading developer of therapeutics that target Galectin receptors to treat cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pro-Pharmaceuticals Reports First Quarter 2010 Financial Results
GALT  
Linked by BusinessWire - May 12, 07:31AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pro-Pharmaceuticals Reports Third Quarter Financial Results
GALT  
Linked by BusinessWire - November 13, 07:45AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of galectin-targeted, carbohydrate therapeutic compounds to treat cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pro-Pharmaceuticals Appoints Arthur R. “Bobby” Greenberg to its Board of Directors
GALT  
Linked by BusinessWire - August 24, 07:00AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pro-Pharmaceuticals Reports Second Quarter and First Six Months 2009 Financial Results
GALT  
Linked by BusinessWire - August 14, 07:30AM from (www.businesswire.com)
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource